Elevated DRD4 promoter methylation increases the risk of Alzheimer's disease in males
- Authors:
- Huihui Ji
- Yunliang Wang
- Danjie Jiang
- Guili Liu
- Xuting Xu
- Dongjun Dai
- Xiaohui Zhou
- Wei Cui
- Jinfeng Li
- Zhongming Chen
- Ying Li
- Dongsheng Zhou
- Qin Zha
- Renjie Zhuo
- Liting Jiang
- Yu Liu
- Lili Shen
- Beibei Zhang
- Lei Xu
- Haochang Hu
- Yuzheng Zhang
- Honglei Yin
- Shiwei Duan
- Qinwen Wang
-
Affiliations: Zhejiang Provincial Key Laboratory of Pathophysiology, School of Medicine, Ningbo University, Ningbo, Zhejiang 315211, P.R. China, Department of Neurology, The 148 Central Hospital of PLA, Zibo, Shandong 255000, P.R. China, Department of Internal Medicine for Cadres, The First Affiliated Hospital of Xinjiang Medical University, Ürümqi, Xinjiang 830000, P.R. China, Geriatric Department, Ningbo Kangning Hospital, Ningbo, Zhejiang 315201, P.R. China, Geriatric Department, Ningbo No. 1 Hospital, Ningbo, Zhejiang 315010, P.R. China, Geriatric Department, The Affiliated Hospital of School of Medicine of Ningbo University, Ningbo, Zhejiang 315200, P.R. China - Published online on: July 27, 2016 https://doi.org/10.3892/mmr.2016.5560
- Pages: 2732-2738
This article is mentioned in:
Abstract
 |
 |
 |
|
Wilson RS, Barnes LL, Mendes de Leon CF, Aggarwal NT, Schneider JS, Bach J, Pilat J, Beckett LA, Arnold SE, Evans DA and Bennett DA: Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology. 59:364–370. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Querfurth HW and LaFerla FM: Alzheimer's disease. N Engl J Med. 362:329–344. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Kubota T: Epigenome: What we learned from Rett syndrome, a neurological disease caused by mutation of a methyl-CpG binding protein. Rinsho Shinkeigaku. 53:1339–1341. 2013.In Japanese. View Article : Google Scholar | |
|
Alonso Vilatela ME, Lopez-Lopez M and Yescas-Gomez P: Genetics of Alzheimer's disease. Genetics of Alzheimer's disease. 43:622–631. 2012. | |
|
Tang LL, Liu Q, Bu SZ, Xu LT, Wang QW, Mai YF and Duan SW: The effect of environmental factors and DNA methylation on type 2 diabetes mellitus. Yi Chuan. 35:1143–1152. 2013.In Chinese. View Article : Google Scholar | |
|
Zhang W, Zheng Y and Hou L: Pharmacogenomic discovery delineating the genetic basis of drug response. Curr Genet Med Rep. 1:143–149. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Wang T, Garcia JG and Zhang W: Epigenetic regulation in particulate matter-mediated cardiopulmonary toxicities: A systems biology perspective. Curr Pharmacogenomics Person Med. 10:314–321. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang D, Hong Q, Shen Y, Xu Y, Zhu H, Li Y, Xu C, Ouyang G and Duan S: The diagnostic value of DNA methylation in leukemia: A systematic review and meta-analysis. PloS One. 9:e968222014. View Article : Google Scholar : PubMed/NCBI | |
|
Cheng J, Wang L, Xu L, Wang H, Liu P, Bu S, Ye M, Zhang L, Wang Q and Duan S: Gender-dependent miR-375 promoter methylation and the risk of type 2 diabetes. Exp Ther Med. 5:1687–1692. 2013.PubMed/NCBI | |
|
Tang LL, Liu Q, Bu SZ, Xu LT, Wang QW, Mai YF and Duan SW: The effect of environmental factors and DNA methylation on type 2 diabetes mellitus. Yi Chuan. 35:1143–1152. 2013.In Chinese. View Article : Google Scholar | |
|
Xu L, Zheng D, Wang L, Jiang D, Liu H, Xu L, Liao Q, Zhang L, Liu P, Shi X, et al: GCK gene-body hypomethylation is associated with the risk of coronary heart disease. Biomed Res Int. 2014:1517232014. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang D, Zheng D, Wang L, Huang Y, Liu H, Xu L, Liao Q, Liu P, Shi X, Wang Z, et al: Elevated PLA2G7 gene promoter methylation as a gender-specific marker of aging increases the risk of coronary heart disease in females. PloS One. 8:e597522013. View Article : Google Scholar : PubMed/NCBI | |
|
Cheng J, Wang Y, Zhou K, Wang L, Li J, Zhuang Q, Xu X, Xu L, Zhang K, Dai D, et al: Male-specific association between dopamine receptor D4 gene methylation and schizophrenia. PloS One. 9:e891282014. View Article : Google Scholar : PubMed/NCBI | |
|
Hodgson N, Trivedi M, Muratore C, Li S and Deth R: Soluble oligomers of amyloid-b cause changes in redox state, DNA methylation and gene transcription by inhibiting EAAT3 mediated cysteine uptake. J Alzheimers Dis. 36:197–209. 2013. | |
|
Ji Huihui, Zhou Xiaohui, Chen Zhongming, Li Ying, Zhou Dongsheng, Zhuo Renjie, Duan Shiwei and Wang Qinwen: Research progress of DNA methylation in Alzheimer's disease. Chi J Cell Biol. 36:1551–1559. 2014. | |
|
Al Akeel R: Role of epigenetic reprogramming of host genes in bacterial pathogenesis. Saudi J Biol Sci. 20:305–309. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Fatemi M, Pao MM, Jeong S, Gal-Yam EN, Egger G, Weisenberger DJ and Jones PA: Footprinting of mammalian promoters: Use of a CpG DNA methyltransferase revealing nucleosome positions at a single molecule level. Nucleic Acids Res. 33:e1762005. View Article : Google Scholar : PubMed/NCBI | |
|
Yu Z, Kong Q and Kone BC: Aldosterone reprograms promoter methylation to regulate αENaC transcription in the collecting duct. Am J Physiol Renal Physiol. 305:F1006–F1013. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Moen EL, Zhang X, Mu W, Delaney SM, Wing C, McQuade J, Myers J, Godley LA, Dolan ME and Zhang W: Genome-wide variation of cytosine modifications between European and African populations and the implications for complex traits. Genetics. 194:987–996. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Moen EL, Stark AL, Zhang W, Dolan ME and Godley LA: The role of gene body cytosine modifications in MGMT expression and sensitivity to temozolomide. Mol Cancer Ther. 13:1334–1344. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Kirley A, Hawi Z, Daly G, McCarron M, Mullins C, Millar N, Waldman I, Fitzgerald M and Gill M: Dopaminergic system genes in ADHD: Toward a biological hypothesis. Neuropsychopharmacology. 27:607–619. 2002.PubMed/NCBI | |
|
Lin WY, Wu BT, Lee CC, Sheu JJ, Liu SH, Wang WF, Tsai CH, Liu HP and Tsai FJ: Association analysis of dopaminergic gene variants (Comt, Drd4 And Dat1) with Alzheimer s disease. J Biol Regul Homeost Agents. 26:401–410. 2012.PubMed/NCBI | |
|
Docherty SJ, Davis OS, Haworth CM, Plomin R, D'Souza U and Mill J: A genetic association study of DNA methylation levels in the DRD4 gene region finds associations with nearby SNPs. Behav Brain Funct. 8:312012. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang H, Herman AI, Kranzler HR, Anton RF, Zhao H, Zheng W and Gelernter J: Array-based profiling of DNA methylation changes associated with alcohol dependence. Alcohol Clin Exp Res. 37(Suppl 1): E108–E115. 2013. View Article : Google Scholar | |
|
Mill J and Heijmans BT: From promises to practical strategies in epigenetic epidemiology. Nat Rev Genet. 14:585–594. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Klengel T, Mehta D, Anacker C, Rex-Haffner M, Pruessner JC, Pariante CM, Pace TW, Mercer KB, Mayberg HS, Bradley B, et al: Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nature Neurosci. 16:33–41. 2013. View Article : Google Scholar | |
|
Provencal N, Suderman MJ, Guillemin C, Massart R, Ruggiero A, Wang D, Bennett AJ, Pierre PJ, Friedman DP, Côté SM, et al: The signature of maternal rearing in the methylome in rhesus macaque prefrontal cortex and T cells. J Neurosci. 32:15626–15642. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Liu X, Zheng Y, Zhang W, Zhang X, Lioyd-Jones DM, Baccarelli AA, Ning H, Fornage M, He K, Liu K and Hou L: Blood methylomics in response to arsenic exposure in a low-exposed US population. J Expo Sci Environ Epidemiol. 24:145–149. 2014. View Article : Google Scholar | |
|
Fiedler U, Wiltfang J, Peters N and Benninghoff J: Advances in the diagnostics of Alzheimer's disease. Nervenarzt. 83:661–673. 2012.In German. View Article : Google Scholar : PubMed/NCBI | |
|
Doumas BT: Standards for total serum protein assays-a collaborative study. Clin Chem. 21:1159–1166. 1975.PubMed/NCBI | |
|
McPherson IG and Everard DW: Serum albumin estimation: Modification of the bromcresol green method. Clinic Chim Acta. 37:117–121. 1972. View Article : Google Scholar | |
|
Yang X, Liu B, Sang Y, Yuan Y, Pu J, Liu Y, Li Z, Feng J, Xie Y, Tang R, et al: Kinetic analysis of the lactate-dehydrogenase-coupled reaction process and measurement of alanine transaminase by an integration strategy. Anal Sci. 26:1193–1198. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Nath RL and Ghosh NK: A preliminary report on the determination of the normal values of serum alkaline phosphatase activity by velocity constant method. Bull Calcutta Sch Trop Med. 10:71–72. 1962.PubMed/NCBI | |
|
Zhang GH, Cong AR, Xu GB, Li CB, Yang RF and Xia TA: An enzymatic cycling method for the determination of serum total bile acids with recombinant 3alpha-hydroxysteroid dehydrogenase. Biochem Biophys Res Commun. 326:87–92. 2005. View Article : Google Scholar | |
|
Roberts RF and Roberts WL: Performance characteristics of a recombinant enzymatic cycling assay for quantification of total homocysteine in serum or plasma. Clin Chim Acta. 344:95–99. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Jaynes PK, Feld RD and Johnson GF: An enzymic, reaction-rate assay for serum creatinine with a centrifugal analyzer. Clin Chem. 28:114–117. 1982.PubMed/NCBI | |
|
Tabacco A, Meiattini F, Moda E and Tarli P: Simplified enzymic/colorimetric serum urea nitrogen determination. Clin Chem. 25:336–337. 1979.PubMed/NCBI | |
|
Whitlow K and Gochman N: Continuous-flow enzymic method evaluated for measurement of serum triglycerides with use of an improved lipase reagent. Clin Chem. 24:2018–2019. 1978.PubMed/NCBI | |
|
Knob M and Rosenmund H: Enzymic determination of total serum cholesterol with centrifugal analyzers (author's transl). Z Klin Chem Klin Biochem. 13:493–498. 1975.In German. PubMed/NCBI | |
|
Hunziker P and Keller H: A mechanized enzymic method for the determination of uric acid (author's transl). Z Klin Chem Klin Biochem. 13:89–96. 1975.In German. PubMed/NCBI | |
|
Asrow G: Semiautomated enzymic micro methods for blood glucose and lactic acid on a single filtrate. Anal Biochem. 28:130–138. 1969. View Article : Google Scholar : PubMed/NCBI | |
|
Egloff M, Léglise D, Duvillard L, Steinmetz J, Boyer MJ, Ruelland A, Agher R and Beucler I: Multicenter evaluation on different analyzers of three methods for direct HDL-cholesterol assay. Ann Biol Clin (Paris). 57:561–572. 1999. | |
|
DaCol P and Kostner GM: Immunoquantification of total apolipoprotein B in serum by nephelometry: Influence of lipase treatment and detergents. Clin Chem. 29:1045–1050. 1983.PubMed/NCBI | |
|
Girault A, Loiseau D and Girault M: Quantitative determination of apolipoprotein A in human serum by laser nephelometry. Ric Clin Lab. 11(Suppl 2): S19–S29. 1981. | |
|
Cazzolato G, Prakasch G, Green S and Kostner GM: The determination of lipoprotein Lp(a) by rate and endpoint nephelometry. Clin Chim Acta. 135:203–208. 1983. View Article : Google Scholar : PubMed/NCBI | |
|
Deyo RA, Pope RM and Persellin RH: Interference by rheumatoid factor with the detection of C-reactive protein by the latex agglutination method. J Rheumatol. 7:279–287. 1980.PubMed/NCBI | |
|
Rifai N and Silverman LM: A simple immunotechnique for the determination of serum concentration of apolipoprotein E. Clin Chim Acta. 163:207–213. 1987. View Article : Google Scholar : PubMed/NCBI | |
|
Ma J, Cheng J, Wang L, Wang H, Xu L, Liu P, Bu S, Zhang L, Le Y, Ye M, et al: No association between IRS-1 promoter methylation and type 2 diabetes. Mol Med Rep. 8:949–953. 2013.PubMed/NCBI | |
|
Zhang LN, Liu PP, Wang L, Yuan F, Xu L, Xin Y, Fei LJ, Zhong QL, Huang Y, Xu L, et al: Lower ADD1 gene promoter DNA methylation increases the risk of essential hypertension. PloS One. 8:e634552013. View Article : Google Scholar : PubMed/NCBI | |
|
Zemek F, Drtinova L, Nepovimova E, Sepsova V, Korabecny J, Klimes J and Kuca K: Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine. Expert Opin Drug Saf. 13:759–774. 2014.PubMed/NCBI | |
|
Pritchard AL, Ratcliffe L, Sorour E, Haque S, Holder R, Bentham P and Lendon CL: Investigation of dopamine receptors in susceptibility to behavioural and psychological symptoms in Alzheimer's disease. Int J Geriatr Psychiatry. 24:1020–1025. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Fratiglioni L, Viitanen M, von Strauss E, Tontodonati V, Herlitz A and Winblad B: Very old women at highest risk of dementia and Alzheimer's disease: Incidence data from the Kungsholmen Project, Stockholm. Neurology. 48:132–138. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Penaloza CG, Estevez B, Han DM, Norouzi M, Lockshin RA and Zakeri Z: Sex-dependent regulation of cytochrome P450 family members Cyp1a1, Cyp2e1, and Cyp7b1 by methylation of DNA. FASEB J. 28:966–977. 2014. View Article : Google Scholar : | |
|
Piferrer F: Epigenetics of sex determination and gonadogenesis. Dev Dyn. 242:360–370. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Siegmund KD, Connor CM, Campan M, Long TI, Weisenberger DJ, Biniszkiewicz D, Jaenisch R, Laird PW and Akbarian S: DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons. PloS One. 2:e8952007. View Article : Google Scholar : PubMed/NCBI | |
|
Paula-Lima AC, Tricerri MA, Brito-Moreira J, Bomfim TR, Oliveira FF, Magdesian MH, Grinberg LT, Panizzutti R and Ferreira ST: Human apolipoprotein A-I binds amyloid-beta and prevents Abeta-induced neurotoxicity. Int J Biochem Cell Biol. 41:1361–1370. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Fagan AM, Younkin LH, Morris JC, Fryer JD, Cole TG, Younkin SG and Holtzman DM: Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype. Ann Neurol. 48:201–210. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Emanuele E, Peros E, Tomaino C, Feudatari E, Bernardi L, Binetti G, Maletta R, Micieli G, Bruni AC and Geroldi D: Relation of apolipoprotein(a) size to alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord. 18:189–196. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Solfrizzi V, Panza F, D'Introno A, Colacicco AM, Capurso C, Basile AM and Capurso A: Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease. J Neurol Neurosurg Psychiatry. 72:732–736. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Suszynska-Zajczyk J, Luczak M, Marczak L and Jakubowski H: Inactivation of the paraoxonase 1 gene affects the expression of mouse brain proteins involved in neurodegeneration. J Alzheimers Dis. 42:247–260. 2014.PubMed/NCBI | |
|
Nazef K, Khelil M, Chelouti H, Kacimi G, Bendini M, Tazir M, Belarbi S, El Hadi Cherifi M and Djerdjouri B: Hyperhomocysteinemia is a risk factor for Alzheimer's disease in an Algerian population. Arch Med Res. 45:247–250. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Hosseinzadeh S, Dabidi Roshan V and Pourasghar M: Effects of intermittent aerobic training on passive avoidance test (shuttle box) and stress markers in the dorsal hippocampus of wistar rats exposed to administration of homocysteine. Iran J Psychiatry Behav Sci. 7:37–44. 2013. | |
|
Lu YQ, Luo Y, He ZF, Chen J, Yan BL, Wang Y and Yu Q: Hydroxysafflor yellow A ameliorates homocysteine-induced Alzheimer-like pathologic dysfunction and memory/synaptic disorder. Rejuvenation Res. 16:446–452. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Yarchoan M, Louneva N, Xie SX, Swenson FJ, Hu W, Soares H, Trojanowski JQ, Lee VM, Kling MA, Shaw LM, et al: Association of plasma C-reactive protein levels with the diagnosis of Alzheimer's disease. J Neurol Sci. 333:9–12. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Duong T, Nikolaeva M and Acton PJ: C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's disease. Brain Res. 749:152–156. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Iwamoto N, Nishiyama E, Ohwada J and Arai H: Demonstration of CRP immunoreactivity in brains of Alzheimer's disease: Immunohistochemical study using formic acid pretreatment of tissue sections. Neurosci Lett. 177:23–26. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Ponnayyan Sulochana S, Sharma K, Mullangi R and Sukumaran SK: Review of the validated HPLC and LC-MS/MS methods for determination of drugs used in clinical practice for Alzheimer's disease. Biomed Chromatogr. 28:1431–1490. 2014. View Article : Google Scholar : PubMed/NCBI |
